Oxidation Biology Unit, The Florey Institute of Neuroscience and Mental Health.
Department of Pharmacology and Therapeutics, The University of Melbourne, Parkville, VIC 3010, Australia.
Free Radic Biol Med. 2014 Apr;69:331-7. doi: 10.1016/j.freeradbiomed.2014.01.041. Epub 2014 Feb 7.
Traumatic brain injury (TBI) is in part complicated by pro-oxidant iron elevation independent of brain hemorrhage. Ceruloplasmin (CP) and β-amyloid protein precursor (APP) are known neuroprotective proteins that reduce oxidative damage through iron regulation. We surveyed iron, CP, and APP in brain tissue from control and TBI-affected patients who were stratified according to time of death following injury. We observed CP and APP induction after TBI accompanying iron accumulation. Elevated APP and CP expression was also observed in a mouse model of focal cortical contusion injury concomitant with iron elevation. To determine if changes in APP or CP were neuroprotective we employed the same TBI model on APP(-/-) and CP(-/-) mice and found that both exhibited exaggerated infarct volume and iron accumulation postinjury. Evidence supports a regulatory role of both proteins in defence against iron-induced oxidative damage after TBI, which presents as a tractable therapeutic target.
创伤性脑损伤(TBI)部分由脑出血以外的促氧化剂铁升高引起。铜蓝蛋白(CP)和β-淀粉样蛋白前体(APP)是已知的神经保护蛋白,可通过铁调节减少氧化损伤。我们调查了脑组织中的铁、CP 和 APP,这些组织来自根据损伤后死亡时间分层的对照和 TBI 患者。我们观察到 TBI 后伴随着铁积累,CP 和 APP 诱导。在局灶性皮质挫伤损伤的小鼠模型中也观察到 APP 和 CP 表达升高,同时伴有铁升高。为了确定 APP 或 CP 的变化是否具有神经保护作用,我们在 APP(-/-)和 CP(-/-)小鼠上使用了相同的 TBI 模型,发现两者在损伤后均表现出梗死体积和铁积累的增加。有证据表明,这两种蛋白在 TBI 后对抗铁诱导的氧化损伤具有调节作用,这为治疗提供了一个可行的靶点。